NCT00002271View on ClinicalTrials.gov

An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

NACompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Alovudine

Trial Locations (1)

21205

Johns Hopkins Hosp, Baltimore

Sponsors

Lead Sponsor

Lederle Laboratories

All Listed Sponsors

lead

Lederle Laboratories

INDUSTRY

NCT00002271 - An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects | Biotech Hunter | Biotech Hunter